Geode Capital Management, LLC Cardiff Oncology, Inc. Transaction History

Geode Capital Management, LLC

  • $1.39 Trillion
  • Q2 2025

A detailed history of Geode Capital Management, LLC transactions in Cardiff Oncology, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,498,838 shares of CRDF stock, worth $3.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,498,838
Previous 1,394,429 7.49%
Holding current value
$3.64 Million
Previous $4.38 Million 7.83%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025
BUY
$2.38 - $4.3 $248,493 - $448,958
104,409 Added 7.49%
1,498,838 $4.72 Million
Q1 2025

May 13, 2025
BUY
$3.14 - $4.75 $1.29 Million - $1.95 Million
411,551 Added 41.87%
1,394,429 $4.38 Million
Q4 2024

Feb 12, 2025
BUY
$2.31 - $5.35 $126,232 - $292,356
54,646 Added 5.89%
982,878 $4.27 Million
Q3 2024

Nov 12, 2024
BUY
$2.05 - $2.77 $35,991 - $48,632
17,557 Added 1.93%
928,232 $2.48 Million
Q2 2024

Aug 09, 2024
BUY
$2.22 - $5.89 $1.06 Million - $2.8 Million
475,842 Added 109.43%
910,675 $2.02 Million
Q1 2024

May 13, 2024
BUY
$1.46 - $5.91 $15,661 - $63,396
10,727 Added 2.53%
434,833 $2.32 Million
Q4 2023

Feb 13, 2024
BUY
$0.96 - $1.55 $30,527 - $49,288
31,799 Added 8.11%
424,106 $627,000
Q3 2023

Nov 13, 2023
BUY
$1.38 - $2.18 $15,396 - $24,322
11,157 Added 2.93%
392,307 $545,000
Q2 2023

Aug 11, 2023
SELL
$1.37 - $1.95 $44,322 - $63,086
-32,352 Reduced 7.82%
381,150 $560,000
Q4 2022

Feb 13, 2023
SELL
$1.22 - $1.66 $1,061 - $1,444
-870 Reduced 0.21%
413,502 $578,000
Q3 2022

Nov 14, 2022
BUY
$1.54 - $3.21 $3,483 - $7,261
2,262 Added 0.55%
414,372 $638,000
Q2 2022

Aug 12, 2022
SELL
$1.17 - $2.61 $301,531 - $672,646
-257,719 Reduced 38.48%
412,110 $906,000
Q1 2022

May 13, 2022
BUY
$2.11 - $7.25 $52,211 - $179,401
24,745 Added 3.84%
669,829 $1.66 Million
Q4 2021

Feb 11, 2022
BUY
$5.18 - $7.24 $325,961 - $455,591
62,927 Added 10.81%
645,084 $3.88 Million
Q3 2021

Nov 12, 2021
BUY
$5.01 - $7.58 $336,551 - $509,194
67,176 Added 13.04%
582,157 $3.88 Million
Q2 2021

Aug 13, 2021
BUY
$6.65 - $10.04 $2.04 Million - $3.08 Million
306,526 Added 147.05%
514,981 $3.42 Million
Q1 2021

May 12, 2021
BUY
$9.1 - $19.57 $50,677 - $108,985
5,569 Added 2.74%
208,455 $1.93 Million
Q4 2020

Feb 12, 2021
BUY
$12.02 - $24.71 $1.16 Million - $2.38 Million
96,327 Added 90.4%
202,886 $3.65 Million
Q3 2020

Nov 13, 2020
BUY
$4.25 - $14.19 $281,702 - $940,555
66,283 Added 164.57%
106,559 $1.51 Million
Q2 2020

Aug 13, 2020
BUY
$0.78 - $5.1 $31,415 - $205,407
40,276 New
40,276 $201,000

Others Institutions Holding CRDF

# of Institutions
125
Shares Held
25.8M
Call Options Held
978K
Put Options Held
295K
View Full List

About Cardiff Oncology, Inc.

CRDF Quotes by TradingView
  • Ticker CRDF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,334,900
  • Market Cap $105M
  • Description
  • Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...
More about CRDF
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email